Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theranostics

Showing results (721-730 of 5,522) with videos related to

Pageof 553
Sort By:
Theranostics|March 23, 2021
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axisStephanie Taha-Mehlitz, Gaia Bianco, Mairene Coto-Llerena, et al.
Theranostics|March 23, 2021
Molecular imaging and biochemical response assessment after a single cycle of [<sup>225</sup>Ac]Ac-PSMA-617/[<sup>177</sup>Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [<sup>177</sup>Lu]Lu-PSMA-617 monotherapyFlorian Rosar, Fabian Hau, Mark Bartholomä, et al.
Theranostics|March 23, 2021
miR-375 prevents high-fat diet-induced insulin resistance and obesity by targeting the aryl hydrocarbon receptor and bacterial tryptophanase (<i>tnaA</i>) geneAnil Kumar, Yi Ren, Kumaran Sundaram, et al.
Theranostics|March 23, 2021
MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's diseaseChunmei Liang, Ting Zou, Miaoping Zhang, et al.
Theranostics|March 23, 2021
MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancerJun Liu, Szu-Jung Chen, Ssu-Wei Hsu, et al.
Theranostics|March 23, 2021
Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancerJianqin Wan, Lingling Huang, Jiangting Cheng, et al.
Theranostics|March 23, 2021
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancerShi-Long Zhang, Yu-Qin Mao, Zheng-Yan Zhang, et al.
Theranostics|March 23, 2021
SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signalingHuitao Liu, Jingjing Zhang, Xingxing Xu, et al.
Theranostics|March 23, 2021
SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinomaLing Lin, Shuyi Chen, Hua Wang, et al.
Theranostics|March 23, 2021
Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5<sub>n-3 DPA</sub> productionJuan Lei, Yu Zhou, Huakan Zhao, et al.
Pageof 553

Showing results (721-730 of 5,522) with videos related to

Sort By:
Pageof 553
Theranostics|March 23, 2021
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axisStephanie Taha-Mehlitz, Gaia Bianco, Mairene Coto-Llerena, et al.
Theranostics|March 23, 2021
Molecular imaging and biochemical response assessment after a single cycle of [<sup>225</sup>Ac]Ac-PSMA-617/[<sup>177</sup>Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [<sup>177</sup>Lu]Lu-PSMA-617 monotherapyFlorian Rosar, Fabian Hau, Mark Bartholomä, et al.
Theranostics|March 23, 2021
miR-375 prevents high-fat diet-induced insulin resistance and obesity by targeting the aryl hydrocarbon receptor and bacterial tryptophanase (<i>tnaA</i>) geneAnil Kumar, Yi Ren, Kumaran Sundaram, et al.
Theranostics|March 23, 2021
MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's diseaseChunmei Liang, Ting Zou, Miaoping Zhang, et al.
Theranostics|March 23, 2021
MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancerJun Liu, Szu-Jung Chen, Ssu-Wei Hsu, et al.
Theranostics|March 23, 2021
Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancerJianqin Wan, Lingling Huang, Jiangting Cheng, et al.
Theranostics|March 23, 2021
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancerShi-Long Zhang, Yu-Qin Mao, Zheng-Yan Zhang, et al.
Theranostics|March 23, 2021
SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signalingHuitao Liu, Jingjing Zhang, Xingxing Xu, et al.
Theranostics|March 23, 2021
SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinomaLing Lin, Shuyi Chen, Hua Wang, et al.
Theranostics|March 23, 2021
Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5<sub>n-3 DPA</sub> productionJuan Lei, Yu Zhou, Huakan Zhao, et al.
Pageof 553